Clinical and microbiological characteristics of cryptococcosis at an university hospital in China from 2013 to 2017

Detalhes bibliográficos
Autor(a) principal: Fang,Lan-fang
Data de Publicação: 2020
Outros Autores: Zhang,Piao-piao, Wang,Jie, Yang,Qing, Qu,Ting-ting
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Infectious Diseases
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702020000100007
Resumo: ABSTRACT Background: This study aims to explore the epidemiology, clinical profile and strain characteristics of cryptococcosis from 2013 to 2017 in a major teaching hospital in China. Methods: Trends in antifungal drug susceptibility of 217 consecutive non-repetitive cryptococcal isolates collected from patients of an university hospital in China were analyzed between 2013 and 2017. Of those, 98 isolates were conserved for identification by internal transcribed spacer (ITS) sequencing and matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) system. Multilocus sequence typing (MLST) was used to designate molecular types. Clinical characteristics of the 98 patients with cryptococcosis during the period of 2013-2017 were retrospectively evaluated. Results: There was a trend for gradual increase in the MIC range of fluconazole was from 2013 to 2017. The conserved 98 clinical cryptococcal isolates included 97 C. neoformans and one C. gattii, and 90 (91.8%) isolates belonged to ST5 genotype VNI. Out of the 98 patients with cryptococcosis, 28 (28.6%) were HIV-infected and 32 (32.7%) had no underlying diseases. HIV-infected patients had higher mortality than HIV-uninfected patients (28.6% vs 14.3%, p = 0.147). Conclusions: Most of the patients with cryptococcosis were not HIV-infected in this study, while patients with HIV had a higher mortality. Reduced susceptibility to fluconazole was observed among C. neoformans isolates, most of them belonged to ST5 genotype VNI having an impact on the effective dose of fluconazole.
id BSID-1_544cff357d9ea6d8902f072c326e7f34
oai_identifier_str oai:scielo:S1413-86702020000100007
network_acronym_str BSID-1
network_name_str Brazilian Journal of Infectious Diseases
repository_id_str
spelling Clinical and microbiological characteristics of cryptococcosis at an university hospital in China from 2013 to 2017CryptococcosisCryptococcus neoformansMultilocus sequence typing (MLST)Antifungal susceptibilityHuman immunodeficiency virus (HIV)ABSTRACT Background: This study aims to explore the epidemiology, clinical profile and strain characteristics of cryptococcosis from 2013 to 2017 in a major teaching hospital in China. Methods: Trends in antifungal drug susceptibility of 217 consecutive non-repetitive cryptococcal isolates collected from patients of an university hospital in China were analyzed between 2013 and 2017. Of those, 98 isolates were conserved for identification by internal transcribed spacer (ITS) sequencing and matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) system. Multilocus sequence typing (MLST) was used to designate molecular types. Clinical characteristics of the 98 patients with cryptococcosis during the period of 2013-2017 were retrospectively evaluated. Results: There was a trend for gradual increase in the MIC range of fluconazole was from 2013 to 2017. The conserved 98 clinical cryptococcal isolates included 97 C. neoformans and one C. gattii, and 90 (91.8%) isolates belonged to ST5 genotype VNI. Out of the 98 patients with cryptococcosis, 28 (28.6%) were HIV-infected and 32 (32.7%) had no underlying diseases. HIV-infected patients had higher mortality than HIV-uninfected patients (28.6% vs 14.3%, p = 0.147). Conclusions: Most of the patients with cryptococcosis were not HIV-infected in this study, while patients with HIV had a higher mortality. Reduced susceptibility to fluconazole was observed among C. neoformans isolates, most of them belonged to ST5 genotype VNI having an impact on the effective dose of fluconazole.Brazilian Society of Infectious Diseases2020-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702020000100007Brazilian Journal of Infectious Diseases v.24 n.1 2020reponame:Brazilian Journal of Infectious Diseasesinstname:Brazilian Society of Infectious Diseases (BSID)instacron:BSID10.1016/j.bjid.2019.11.004info:eu-repo/semantics/openAccessFang,Lan-fangZhang,Piao-piaoWang,JieYang,QingQu,Ting-tingeng2020-04-02T00:00:00Zoai:scielo:S1413-86702020000100007Revistahttps://www.bjid.org.br/https://old.scielo.br/oai/scielo-oai.phpbjid@bjid.org.br||lgoldani@ufrgs.br1678-43911413-8670opendoar:2020-04-02T00:00Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)false
dc.title.none.fl_str_mv Clinical and microbiological characteristics of cryptococcosis at an university hospital in China from 2013 to 2017
title Clinical and microbiological characteristics of cryptococcosis at an university hospital in China from 2013 to 2017
spellingShingle Clinical and microbiological characteristics of cryptococcosis at an university hospital in China from 2013 to 2017
Fang,Lan-fang
Cryptococcosis
Cryptococcus neoformans
Multilocus sequence typing (MLST)
Antifungal susceptibility
Human immunodeficiency virus (HIV)
title_short Clinical and microbiological characteristics of cryptococcosis at an university hospital in China from 2013 to 2017
title_full Clinical and microbiological characteristics of cryptococcosis at an university hospital in China from 2013 to 2017
title_fullStr Clinical and microbiological characteristics of cryptococcosis at an university hospital in China from 2013 to 2017
title_full_unstemmed Clinical and microbiological characteristics of cryptococcosis at an university hospital in China from 2013 to 2017
title_sort Clinical and microbiological characteristics of cryptococcosis at an university hospital in China from 2013 to 2017
author Fang,Lan-fang
author_facet Fang,Lan-fang
Zhang,Piao-piao
Wang,Jie
Yang,Qing
Qu,Ting-ting
author_role author
author2 Zhang,Piao-piao
Wang,Jie
Yang,Qing
Qu,Ting-ting
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Fang,Lan-fang
Zhang,Piao-piao
Wang,Jie
Yang,Qing
Qu,Ting-ting
dc.subject.por.fl_str_mv Cryptococcosis
Cryptococcus neoformans
Multilocus sequence typing (MLST)
Antifungal susceptibility
Human immunodeficiency virus (HIV)
topic Cryptococcosis
Cryptococcus neoformans
Multilocus sequence typing (MLST)
Antifungal susceptibility
Human immunodeficiency virus (HIV)
description ABSTRACT Background: This study aims to explore the epidemiology, clinical profile and strain characteristics of cryptococcosis from 2013 to 2017 in a major teaching hospital in China. Methods: Trends in antifungal drug susceptibility of 217 consecutive non-repetitive cryptococcal isolates collected from patients of an university hospital in China were analyzed between 2013 and 2017. Of those, 98 isolates were conserved for identification by internal transcribed spacer (ITS) sequencing and matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) system. Multilocus sequence typing (MLST) was used to designate molecular types. Clinical characteristics of the 98 patients with cryptococcosis during the period of 2013-2017 were retrospectively evaluated. Results: There was a trend for gradual increase in the MIC range of fluconazole was from 2013 to 2017. The conserved 98 clinical cryptococcal isolates included 97 C. neoformans and one C. gattii, and 90 (91.8%) isolates belonged to ST5 genotype VNI. Out of the 98 patients with cryptococcosis, 28 (28.6%) were HIV-infected and 32 (32.7%) had no underlying diseases. HIV-infected patients had higher mortality than HIV-uninfected patients (28.6% vs 14.3%, p = 0.147). Conclusions: Most of the patients with cryptococcosis were not HIV-infected in this study, while patients with HIV had a higher mortality. Reduced susceptibility to fluconazole was observed among C. neoformans isolates, most of them belonged to ST5 genotype VNI having an impact on the effective dose of fluconazole.
publishDate 2020
dc.date.none.fl_str_mv 2020-02-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702020000100007
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702020000100007
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1016/j.bjid.2019.11.004
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
dc.source.none.fl_str_mv Brazilian Journal of Infectious Diseases v.24 n.1 2020
reponame:Brazilian Journal of Infectious Diseases
instname:Brazilian Society of Infectious Diseases (BSID)
instacron:BSID
instname_str Brazilian Society of Infectious Diseases (BSID)
instacron_str BSID
institution BSID
reponame_str Brazilian Journal of Infectious Diseases
collection Brazilian Journal of Infectious Diseases
repository.name.fl_str_mv Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)
repository.mail.fl_str_mv bjid@bjid.org.br||lgoldani@ufrgs.br
_version_ 1754209244723281920